IPP Bureau
India committed to strengthen traditional medicine practice by bolstering evidence-based research: Sonowal
By IPP Bureau - February 13, 2023
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
Briefs: Biocon, Laurus Labs and Smruthi Organics
By IPP Bureau - February 13, 2023
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
Johnson & Johnson MedTech India partners with Karkinos to upskill professionals in cancer care
By IPP Bureau - February 13, 2023
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
Global Hospital launches robotic surgery technology ‘Da Vinci Xi System’
By IPP Bureau - February 13, 2023
Sun Pharma Announces USFDA Approval for Generic Lenalidomide Capsules
By IPP Bureau - February 11, 2023
The respective product approval is based on Revlimid Capsules, 5mg, 10mg, 15mg, 25mg and 2.5mg, 20mg as a reference product
Glenmark Pharma reports Q3 FY 2022-23 revenue growth of 9.2%; PAT growth of 21.3%
By IPP Bureau - February 11, 2023
Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY
Dishman Carbogen Amcis Q3 FY23 revenue up 14%
By IPP Bureau - February 11, 2023
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
Artificial intelligence facilitates low-cost drug repurposing, says GlobalData
By IPP Bureau - February 11, 2023
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Pfizer appoints Meenakshi Nevatia as MD and Additional Director
By IPP Bureau - February 10, 2023
She is a seasoned leader with nearly 30 years of business leadership and consulting experience with top companies such as Mckinsey and Co, Novartis Pharmaceuticals and Stryker India Pvt. Ltd.
Lupin receives approval from USFDA for Glycopyrrolate Injection USP
By IPP Bureau - February 10, 2023
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
Healthcare Global Enterprises revenue up 19%
By IPP Bureau - February 10, 2023
Technology and innovation play a pivotal role towards enhancing healthcare systems, increasing access to healthcare services, and reducing costs of therapies and consultations
Aurobindo Pharma Q3 FY23 net profit down 18.7% at Rs 491 Crores
By IPP Bureau - February 10, 2023
Revenue from operations during the quarter was up by 6.7 per cent to Rs 6,407.10 crore against Rs 6,002.2 in the same period last fiscal.
Dr. Reddy’s included in Bloomberg Gender-Equality Index for 6th year in a row
By IPP Bureau - February 09, 2023
The company has also been named among global sustainability leaders for the 7th year in a row in the Dow Jones Sustainability Index in the Emerging Markets category
Windlas Biotech appoints Komal Gupta as CEO
By IPP Bureau - February 09, 2023
The company is in the process of appointing the new Chief Financial Officer shortly and in the interim, Komal Gupta will continue as CFO
Jagsonpal Q3 FY23 revenues grew by 11.6% to Rs. 60.1 Cr; PAT up by 47.1%
By IPP Bureau - February 09, 2023
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
